The reasons are simple - 1) Less price erosion than US generics many ROW markets operate on tender-based or branded-generic models with less competitive intensity 2) Higher entry barriers than domestic Indiarequires regulatory filings (EU GMP, WHO PQ, ANVISA), distribution infrastructure, and local market knowledge 3) Branded potential - unlike the US where generics are interchangeable, many ROW markets allow branded generics that can command premium pricing 4) Large unmet need - healthcare access in Africa, LatAm, and Southeast Asia is expanding, creating genuine volume growth (not just market share battles) Lets see who is doing well here - 13) Strides Pharma - The Ex-US Transformation Story + Controlled drug substances Strides transformation from a US-centric generics player to a diversified international formulator is one of the most underappreciated stories in Indian pharma
Mounjaro is a tool to support your weight management journey, not a magic bullet
If you are on this medication with the help of a physician, how are you being proactive
If you have more specific questions about handling protocols or want to discuss your research needs, our team is always available
PlexusDx providers distinguish between medication-related and situational anxiety to guide treatment adjustments
But as Kuminski suggests, The goal isnt to look perfect right now
